Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07308938) titled 'Fluorometholone Study' on Dec. 26, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Vishal Jhanji
Condition:
Keratitis Bacterial
Corneal Ulcer (Diagnosis)
Intervention:
Drug: Adjunctive Topical Fluorometholone (FML) 0.1%
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 31, 2026
Target Sample Size: 174
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07308938
Published by HT Digital Conten...